Mutation of epidermal growth factor receptor gene in non-small cell lung cancer patients with different biological samples and clinical pathophysiological characteristics
Lei JIANG,Yu-qiang LI,Hong-zhi SUN,Chen LI
DOI: https://doi.org/10.13339/j.cnki.sglc.20170511.020
2017-01-01
Abstract:Objective To study the relationship between mutation of epidermal growth factor receptor(EGFR) gene of patients with non―small cell lung cancer(NSCLC) and origin of sample, and discuss the feasibility and reliability of tissue sample, blood sample and malignant pleural effusion sample in detection of EGFR gene mutation. Methods From July 1, 2013 to July 1, 2016, a total of 157 tissue samples, 23 blood samples and 20 malignant pleural effusion samples of NSCLCpatients from De-partment of Thoracic Surgery, Oncology and General Surgery in First Affiliated Hospital of Jinzhou Medical University were collected. The patients included 127 males and 73 females, aged 35―82 years old with mean age of 61 years old, 67 cases≤61―year―old and 133 cases > 61―year―old. The E.Z.N.A.TM Tissue DNA Kit (OMEGA company) was used to extract DNA of tissue sample, the Human EGFR Gene Mutation Fluorescence Polymerase Chain Reaction(PCR) Diagnostic Kit was used to extract the DNA of blood sample and malignant pleural effusion sample, and fluorescent quantitation RCR was used to detect the EGFR. Results The EGFR gene mutation rate of tissue samples was 42.7 %(67/157), blood samples was 34.8 % and leural effusion sample was 80.0%(16/20). The EGFR gene mutation rates of tissue samples were different in different gender(χ2=1.837, P=0.274), different age(χ2= 0.645, P = 0.247) and TNM staging(χ2= 1.645, P = 0.427), and there was no significant differ-ence between the groups . The differences in smoking and non―smoking patients were statistically significant (χ2 = 2 . 674 , P=0.036). There was no significant difference in EGFR gene mutation rates between gross and punctured samples(χ2=2.165, P = 0.374). The EGFR gene mutation rate of metastatic was higher than that of primary tumor, and the difference was statisti-cally significant(χ2=4.148, P=0.043). The EGFR gene mutation rate of adenocarcinoma was higher than that of non―adenocar-cinoma, and the difference was statistically significant(χ2=5.274, P=0.021). Conclusion The patients with adenocarcinoma showed high incidence rate of EGFR gene mutation in NSCLC patients, which is unrelated to gender, age, TNM staging, smok-ing and physical state;the EGFR mutation rate of metastatic focus is higher than that of primary focus, the patients with pleu-ral effusion have a higher EGFR mutation rate than those without pleural effusion, the patients with adenocarcinoma have higher EGFR gene mutation rate than those without adenocarcinoma. Due to the tumor heterogeneity, tumor tissues from differ-ent positions(primary and metastatic) and parts should be obtained for detection as early as possible, otherwise EGFR genetic mutation of blood sample and pleural effusion sample should be detected.